Pharmacoeconomics is a branch of health economics related to the most economical and efficient use of pharmaceuticals. Pharmacoeconomics research identifies measures and compares the costs and outcomes of pharmaceutical products and services. Pharmacoeconomics can play a significant role in the efficient allocation of resources in healthcare systems with constrained budgets.
The purpose of the Pharmacoeconomics Journal is to compares the value of one pharmaceutical drug or drug therapy to another. Pharmacoeconomics is an Open Access journal aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports and short communications. In all the areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
HILARIS SRL through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. An HILARIS SRL host over 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences annually all over the world.
Rapid Publication Service
Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Articles published in Pharmacoeconomics: Open Access have been cited by esteemed scholars and scientists all around the world. Pharmacoeconomics: Open Access has got h-index 5 , which means every article in Pharmacoeconomics: Open Access has got 5 average citations.
Short Communication
Short Communication
Pharmacoeconomics: Open Access received 95 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 